Nowadays pancreatic cancer prognosis

Med Clin (Barc). 2019 May 17;152(10):395-396. doi: 10.1016/j.medcli.2018.12.005. Epub 2019 Feb 2.
[Article in English, Spanish]
No abstract available

Publication types

  • Review

MeSH terms

  • Aged
  • Aged, 80 and over
  • Albumin-Bound Paclitaxel / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Chemotherapy, Adjuvant
  • Comorbidity
  • Deoxycytidine / administration & dosage
  • Deoxycytidine / analogs & derivatives
  • Diabetes Mellitus / epidemiology
  • Diet
  • Drug Resistance, Neoplasm
  • Early Detection of Cancer
  • Fluorouracil / administration & dosage
  • Gemcitabine
  • Genetic Predisposition to Disease
  • Humans
  • Irinotecan / administration & dosage
  • Leucovorin / administration & dosage
  • Neoadjuvant Therapy
  • Neoplasm Metastasis
  • Oxaliplatin / administration & dosage
  • Palliative Care
  • Pancreatectomy
  • Pancreatic Neoplasms / diagnosis
  • Pancreatic Neoplasms / etiology
  • Pancreatic Neoplasms / mortality*
  • Pancreatic Neoplasms / therapy
  • Poly(ADP-ribose) Polymerase Inhibitors / therapeutic use
  • Prognosis
  • Radiosurgery
  • Risk Factors
  • Spain / epidemiology

Substances

  • Albumin-Bound Paclitaxel
  • Poly(ADP-ribose) Polymerase Inhibitors
  • folfirinox
  • Oxaliplatin
  • Deoxycytidine
  • Irinotecan
  • Leucovorin
  • Fluorouracil
  • Gemcitabine